Inventor

GULATI ANMOL

US11 patents

⚠️ This page may combine multiple inventors who share the name “GULATI ANMOL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GOOGLE LLC

5 patents

US12373666B2Jul 29, 2025

Convolution-augmented transformer models

GOOGLE LLC0 citations59

US12079703B2Sep 3, 2024

Convolution-augmented transformer models

GOOGLE LLC0 citations59

US12482455B2Nov 25, 2025

Systems and methods for training dual-mode machine-learned speech recognition models

GOOGLE LLC0 citations51

US12094453B2Sep 17, 2024

Fast emit low-latency streaming ASR with sequence-level emission regularization utilizing forward and backward probabilities between nodes of an alignment lattice

GOOGLE LLC0 citations51

US12190869B2Jan 7, 2025

Optimizing inference performance for conformer

GOOGLE LLC0 citations49

MERCK SHARP & DOHME LLC

4 patents

US12319671B2Jun 3, 2025

1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME LLC0 citations48

US12516039B2Jan 6, 2026

N-linked isoquinoline amides as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME LLC0 citations47

US12570640B2Mar 10, 2026

2-aminoquinazolines as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME LLC0 citations46

US12540131B2Feb 3, 2026

N-(heteroaryl) quinazolin-2-amine derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME LLC0 citations42

MERCK SHARP & DOHME

1 patent

US11161854B2Nov 2, 2021

Indazolyl-spiro[2.2]pentane-carbonitrile derivatives as LRRK2 inhibitors, pharmaceutical compositions, and uses thereof

MERCK SHARP & DOHME2 citations68

GOOGLE INC

1 patent

US10789283B2Sep 29, 2020

Systems and methods for notifying an author of contextual suggested content

GOOGLE INC0 citations32